MICRON BIO-SYSTEMS LTD
Company number 03423831 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Credit Analysis: MICRON BIO-SYSTEMS LTD
1. Credit Opinion: CONDITIONAL
Reasoning: The credit decision must be conditional due to severe data limitations. As a Micro entity, the company files minimal accounts, and no financial statements (balance sheet, P&L, cash flow) have been provided for review. While the company demonstrates longevity (incorporated 1997) and operational stability, the absence of financial data makes it impossible to properly assess payment capability, leverage, or cash flow adequacy. Any credit facility would require full financial disclosure and likely personal guarantees from the PSCs before approval can be considered.
2. Financial Strength
Severely Limited Visibility
- Share Capital: Only £100 — exceptionally thin for a 27-year-old manufacturing business, suggesting retained earnings or director loans fund operations rather than equity
- Micro Entity Status: Filing as a Micro entity (turnover ≤ £632k, balance sheet ≤ £316k, ≤10 employees) indicates this is a very small operation
- No Financial Statements Available: Without sight of net assets, current ratios, or gearing, balance sheet health cannot be evaluated
- Longevity Factor: 27 years of trading suggests survival through multiple economic cycles, which is positive, but does not confirm current financial health
Assessment: Unable to determine. The £100 share capital is a concern — it suggests the business may be operating with minimal equity cushion, potentially relying on director loans or retained profits.
3. Cash Flow Assessment
Cannot Be Completed
No financial data is available to assess: - Working capital position (net current assets) - Cash conversion or operating cash flows - Debt service coverage - Liquidity ratios
Indirect Indicators: - Filing compliance is current (no overdue accounts or confirmation statements) — suggests no administrative distress - Multiple directors and a secretary indicate some organizational structure - Family-controlled (Parfitt family: Dr David Parfitt 50-75%, Steven Thomas Parfitt 25-50%) — concentrated ownership can mean faster decision-making but also key-person risk
4. Monitoring Points
If credit is extended, the following should be required and monitored:
| Metric | Requirement |
|---|---|
| Full Accounts | Require submission of full (not Micro) accounts or management accounts |
| Personal Guarantees | Essential from Dr David Parfitt and Steven Thomas Parfitt given concentrated ownership and thin share capital |
| Trading Performance | Monthly/quarterly management accounts showing turnover, gross margin, and net cash position |
| Sector Monitoring | Bio-technology/agri-tech is niche; monitor regulatory changes affecting animal health products |
| Key-Person Risk | Dr David Parfitt (50-75% owner) is critical; consider key-person insurance as condition |
| Director Loans | Clarify extent of director loan accounts — these may rank ahead of bank debt |
| Filing Status | Ongoing monitoring for any accounts or confirmation statements becoming overdue |